National Health Investors, Inc.

NYSE NHI

National Health Investors, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2024: USD 187.17 M

National Health Investors, Inc. EBIT is USD 187.17 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 28.13% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

National Health Investors, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 146.08 M, a 78.77% change year over year.
National Health Investors, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 81.71 M, a -51.39% change year over year.
National Health Investors, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 168.11 M, a -25.06% change year over year.
National Health Investors, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 224.33 M, a 5.06% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

NYSE: NHI

National Health Investors, Inc.

CEO	Mr. D. Eric Mendelsohn
IPO Date	Oct. 9, 1991
Location	United States
Headquarters	222 Robert Rose Drive
Employees	26
Sector	Real Estate
Industries Health Care REITs Diversified REITs

Description

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Key trends

Past 5 years